Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis
Figures
Figure 1 with 2 supplements
-
Figure 1—source data 1
- https://doi.org/10.7554/eLife.25624.004
Figure 1—figure supplement 1
Figure 1—figure supplement 2
Figure 2 with 4 supplements
Figure 2—figure supplement 1
Figure 2—figure supplement 2
Figure 2—figure supplement 3
Figure 2—figure supplement 4
Figure 3
Figure 4
Figure 5
Figure 6 with 3 supplements
-
Figure 6—source data 1
- https://doi.org/10.7554/eLife.25624.018
Figure 6—figure supplement 1
Figure 6—figure supplement 2
Figure 6—figure supplement 3
Figure 7
Figure 8 with 1 supplement
Figure 8—figure supplement 1
Figure 9
Figure 10
Tables
Table 1
-
Table 1—source data 1
- https://doi.org/10.7554/eLife.25624.016
Table 2
-
Table 2—source data 1
- https://doi.org/10.7554/eLife.25624.027
Additional files
-
Supplementary file 1
- https://doi.org/10.7554/eLife.25624.029
-
Supplementary file 2
- https://doi.org/10.7554/eLife.25624.030
-
Supplementary file 3
- https://doi.org/10.7554/eLife.25624.031
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis
eLife 6:e25624.
https://doi.org/10.7554/eLife.25624